2.60Open2.65Pre Close48 Volume70 Open Interest45.00Strike Price15.71KTurnover109.42%IV2.48%PremiumDec 20, 2024Expiry Date2.23Intrinsic Value100Multiplier4DDays to Expiry1.17Extrinsic Value100Contract SizeAmericanOptions Type0.6905Delta0.0676Gamma14.10Leverage Ratio-0.2660Theta0.0030Rho9.73Eff Leverage0.0168Vega
Viking Therapeutics Stock Discussion
loading...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
No comment yet